<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">Influenza</z:e> virus still poses a major threat to human health </plain></SENT>
<SENT sid="1" pm="."><plain>Despite widespread vaccination programmes and the development of drugs targeting essential <z:mp ids='MP_0001799'>viral</z:mp> proteins, the extremely high mutation rate of <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> virus still leads to the emergence of new pathogenic virus strains </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, it has been suggested that cellular cofactors that are essential for <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> might be better targets for antiviral therapy </plain></SENT>
<SENT sid="3" pm="."><plain>It has previously been reported that <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> virus efficiently infects Epstein-Barr virus-immortalized B cells, whereas Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells are virtually resistant to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Using this cellular system, it has been shown here that an active NF-kappaB signalling pathway is a general prerequisite for <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> of human cells </plain></SENT>
<SENT sid="5" pm="."><plain>Cells with low NF-kappaB activity were resistant to <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e>, but became susceptible upon activation of NF-kappaB </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, blocking of NF-kappaB activation severely impaired <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> of otherwise highly susceptible cells, including the human <z:mp ids='MP_0008714'>lung carcinoma</z:mp> cell lines A549 and U1752 and primary human cells </plain></SENT>
<SENT sid="7" pm="."><plain>On the other hand, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with <z:e sem="disease" ids="C0042214" disease_type="Disease or Syndrome" abbrv="">vaccinia</z:e> virus was not dependent on an active NF-kappaB signalling pathway, demonstrating the specificity of this pathway for <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>These results might be of major importance for both the development of new antiviral therapies and the understanding of <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> virus biology </plain></SENT>
</text></document>